| 1 |
Huang Y-C., Hasegawa, H., Wang, S-W., Lin, Y-C., Chiou, S-S.,
Wu D-C., Tsai, E-M., Saito S., Yamaguchi N., and
Yokoyama, K.:
JDP2 controls differentiation and cellular senescence via inhibition
of histone modification. J. of Biomedicine and Biotechnology
2011:569034 (2011). |
| 2 |
Kawashima, R., Abei, M., Fukuda, K., Nakamura, K., Murata,
T., Wakayama, M., Seo E., Hasegawa, N., Mizuguchi H., Obata, Y.,
Hyodo, I., Hamada, H. and
Yokoyama, K.:
EpCAM- and EGFR-targeted selective gene therapy for billary cancers
using Z233-fiber modified adenovirus. Inter. J. Cancer 129, 1244-1253 (2011).
|
| 3 |
Murata, T., Noda, C., Saito, S., Kawashima, D.,
Sugimoto, D., Isomura, H., Kanda, T., Yokoyama, K.
and Tsurumi, T.: Jun dimerization protein 2(JDP2) suppresses
Epstein-Bar Virus reactivation from latency. J. Biol. Chem.
286, 22007-22016 (2011). |
| 4 |
Tang, X., O’Reilly, A., Asano, M., Merrill, J.
C., Yokoyama, K. and Amar S.: p53 peptide prevents LITAF-induced TNF-alpha-mediated
mouse lung lesions and endotoxic shock. Curr. Mol. Med. 11, 439-452
(2011). |
| 5 |
Wang, S-W.,
Lee. J-K., Ku C-C., Chiou S-S., Lin S. C-L., Ho
M-F., Wu D-C., and Yokoyama, K.: Jun
dimerization 2 in oxygen restriction; control of
senescence. Curr. Pharmaceutical Design 17,
2278-2289 (2011)
[Selected as a Cover of the Journal] |
| 6 |
Saito, S.,Wang, S-W.,
Ku C-C., Lin S. C-H., Wu D-C., Maruyama. Y and Yokoyama, K.:
Human aminion-derived pluripotent stem cells as
promising source for regenerative medicine and
tissue engineering.
J. Bioengineering &
Biomedical Sciences S2-005. doi:
10.4172/2155-9538. S2-005
(2011). |
| 7 |
Hsiao, H., Huang, S-E., Ku, C-C, and Yokoyama, K.:
International Society for Stem Cell Research
2011, ninth annual meeting in Toronto (June
15-June 18, 2011). Kaohsiung
Journal of Medical Sciences 28,
296-298 (2012). |
| 8 |
Huang,
S-E., Hsiao, H., Ku, C-C, and Yokoyama, K.: Cold Spring Harbor
Asia/International
Society for Stem Cell Research 2011 meeting; Cellular
programs and reprogramming (October 24-28, 2011). Kaohsiung Journal of
Medical Sciences 28, 352-354 (2012).
|
| 9 |
Chen, C-W.,
Chen, T-Y., Tsai L-L., Lin C-L., Yokoyama,
K.,
Lee, W-S., Chiueh. C. C., and Hsu, C.: Inhibition of autophagy as a
therapeutic strategy of iron-induced brain injury after hemorrhage. Autophagy, 8, 1510-120
(2012) |
| 10 |
Darlyuk-Saadon, I., Weidenfeld-Baranboim, K., Yokoyama, K.,
Hai T.,
and
Aronheim, A.; The bZIP repressor proteins, the c-Jun
dimerization
protein 2, and the Activating Transcription factor 3, recruit
multiple members of HDAC to the ATF3 promoter.
Biochim. Biophys. Acta 1819,
1142-1153 (2012). |
| 11 |
Saito, S., Lin, Y-C, Murayama, Y., Hashimoto, K.,
and Yokoyama,
K. Human
amnion-derived cells as a reliable source of stem cells. Cur.
Mol. Med.
12,
1340-1349
(2012).
[Selected as a highlighted article] |
| 12 |
Maruyama, K., Fukasaka, M., Vandenbon, A., Saitoh, T., Kawasaki, T., Kondo,
T., Yokoyama K., Kidoya, H., Takakura, N., Stanley, D., Takeuchi, O.
and Akira, S. The transcription factor Jdp2 controls bone homeostasis and
antibacterial immunity by regulating osteroclast and neutrophil
differentiation.
Immunity
37,
1024-1036
(2012)
|
| 13 |
Tanigawa, S., and Yokoyama, K. : JDP2 is a cofactor of
antioxidant regulatory complex and participates in ROS homeostasis.
Introduction to genetic (DNA methylation and gene regulation).
ed. by J. Wan, iConcept press, USA.
pp. 201-220.
(2013) |
| 14 |
Chen, Y., Hwang, S-L., Chen, V.S.F.,
Chung, N, P.Y., Wang, S-R., Lin C-W., Hsieh, Y-J., Chang, K-P.,
Kung, S-S., Wu, Y-C., Chu, C-W., Tai, H-T., Gao, G. F., Zheng, B., Yokoyama,
K.,
Austyn, J. M., and Lin, C-L, S.; Binding of HIV-1 gp120 to DC-SIGN
promotes ASK-1-dependent activation-induced apoptosis of human
dendritic cells.
PLoS Pathogens 9,
e1003100 (2013). |
| 15 |
Hsu N. C., Huang, Y-F., Yokoyama, K., Chen F-M., and Hou M-F.;
Methylation of BRACA1 promoter region is associated with unfavorable
prognosis in women with early-stage breast cancer.
PLoS ONE 8,
e56256 (2013). |
| 16 |
Hasegawa, N., Abei, M., Yokoyama, K., Fukuda, K., Seo, E.,
Kawashima, R., Nakano, Y., Yamada, T., Nakade, K., Hamada, H.,
Obata, Y and Hyodo, I.; Cyclophosphamide enhances antitumor
efficiency of oncolytic adenovirus expressing uracil
phosphoribosyltransferase in syrian hamsters.
Int. J.
Cancer 133,
1479-1488 (2013). |
| 17 |
Chiou, S-S., Wang,
S-W., Wu, D-C., Lin, Y-C., Kao, L-P., Kuo, K-K., Wu, C-C., Chai,
C-Y., Lin, C-C., Lee, C-Y., Liao, Y-M., Wuputra, K., Yang, Y-H.,
Wang, S-W., Ku, C-C., Nakamura, Y., Saito, S., Hasegawa, H.,
Yamaguchi, N., Miyoshi, H., Lin, C-S., Eckner, R., and Yokoyama
K.K.; Control of oxidative stress and generation of induced pluripotent stem cell-like cells by Jun dimerization protein 2.
Cancers 5,
959-984 (2013). |
| 18 |
Wang S-W., Wang, S. S-W., Wu, D-C., Lin
Y-C., Ku C-C., Wu, C-C., Chai C-Y., Lee J-N.,
Tsai, E-M., Lin, S. C-L., Yang, R-C., Ko, Y-C., Yu, H-S., Huo, C.,
Chuu, C-P., Murayama, Y., Nakamura, Y., Hashimoto, S., Matsushima,
K., Jin, C., Lin, C-S., K., Saito, S. and Yokoyama, K.;
Androgen receptor-mediated apoptosis in bovine testicular induced
pluripotent stem cells in response to phthalate esters. Cell
Death Disease,
4, e921 (2013) |
| 19 |
Tanigawa, S., Lee,
C-H., Lin C-S., Ku, C-C., Hasegawa, H., Qin, S., Kawahara, A.,
Korenori. Y., Qin, S., Miyamori, K., Noguchi, M., Lee, L-H., Lin
Y-C., Lin, S. C-L., Nakamura, Y., Jin C., Yamaguchi, N., Eckner, R.,
Hou, D-X., and Yokoyama, K.: Jun dimerization protein 2 is a
novel critical component of the Nrf2/MafK complex regulating the
response to ROS homeostasis. Cell Death & Disease,
4, e907 (2013). |
| 20 |
Hsu, N. C-H., Nien, P-Y.,
Yokoyama, K.,
Chu, R-Y., and Hou M-F.: High chondroitin sulfate proteoglycan 4
expression correlates with poor outcome in patients with breast
cancer.
Biochem. Biophys. Res. Commu.,
441,
514-518
(2013). |
|
Kaohsiung Medical University
Center of Excellence for Environmental Medicine
Graduate Institute of Medicine
100 shih-Chuan 1st
Road, San Ming District,
Kaohsiung, 80708, Taiwan
|
